Number of Employees: Approximately 500
Welcome to Philip Morris Australia. Established in 1954 and based in Melbourne, we were the first affiliate in the world to produce Philip Morris International brands outside of the United States. As part of Philip Morris International’s review of its global manufacturing operations, Australian cigarette production was discontinued and transitioned to the company’s Korean affiliate in 2014. As a leading manufacturing affiliate, Korea is equally committed to maintaining and enhancing the quality of tobacco products manufactured for sale in Australia in line with Australian and international standards and regulations. Philip Morris Limited continues to be headquartered in Melbourne and maintains a strong ongoing commercial presence in Australia, employing more than 500 people across the country.
Philip Morris Australia is a signatory to the Australian Packaging Covenant (APC), a sustainable packaging initiative which aims to change the culture of business to design more sustainable packaging, increase recycling rates and reduce packaging litter. It is an agreement between government, industry and community groups to find and fund solutions to address packaging sustainability issues. Philip Morris Australia’s APC Action Plan is available HERE and our 2015 annual report is available HERE.We also partner with Terracycle, a company that has developed a recycling solution for previously ‘unrecycleable’ material, including cigarette waste. In 2014, Terracycle collected more than three million cigarette butts for recycling.
Smoking and Health
Tobacco products, including cigarettes, are dangerous and addictive. There is overwhelming medical and scientific evidence that smoking causes lung cancer, heart disease, emphysema, and other serious diseases.
All tobacco products are addictive. It can be very difficult to quit smoking, but this should not deter smokers who want to quit from trying to do so.
Public health officials have concluded that secondhand smoke from cigarettes causes serious diseases in non-smokers, including lung cancer and heart disease. We believe the public health conclusions on secondhand smoke are sufficient to support smoking restrictions in public places.
Philip Morris International (PMI) supports comprehensive regulation of tobacco products based on the principle of harm reduction.
To be effective, tobacco regulatory policy must be evidence-based, apply to all tobacco products, and should take into account the views of all legitimate stakeholders including public health authorities, government finance authorities, tobacco manufacturers, and other members of the tobacco supply chain. Regulatory policy must consider the potential to trigger adverse consequences which undermine public health objectives, such as increasing the demand for illicit cigarettes.
While we support comprehensive, effective tobacco regulation, we do not support regulation that prevents adults from buying and using tobacco products or that imposes unnecessary impediments to the operation of the legitimate tobacco market. In that regard, we oppose measures such as generic packaging, point of sale display bans, total bans on communications to adult consumers, and bans on the use of all ingredients in tobacco products.